Concepedia

MN Dickler

MD

3

Publications

57

Citations

3

H-Index

2013

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Dana-Farber Cancer Institute

MN Dickler is an author at Memorial Sloan Kettering Cancer Center specializing in pharmacotherapy, radiation oncology, and breast cancer.

Top concepts

Publications per year

2013–2018

3

Publications

3

Abstract PD5-10: A first-in-human phase I study to evaluate the oral selective estrogen receptor degrader (SERD), GDC-0927, in postmenopausal women with estrogen receptor positive (ER+) HER2-negative metastatic breast cancer (BC)

MN Dickler, JA Perez Fidalgo, IA Mayer et al. · Cancer Research · 2018 · 30 citations

, , +20

Abstract P1-09-01: A phase 1b study of abemaciclib plus pembrolizumab for patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC)

HS Rugo, Peter Kabos, MN Dickler et al. · Cancer Research · 2018 · 16 citations

, , +16

Abstract OT3-2-07: Phase I study of ARN-810, a novel selective estrogen receptor degrader, in post-menopausal women with locally advanced or metastatic estrogen receptor positive breast cancer

IA Mayer, Aditya Bardia, MN Dickler et al. · Cancer Research · 2013 · 11 citations

, , +17

Rows per page

1–3 of 3